Flexion Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
COLELLA SAMUEL D director
 Common Stock 18,726 $13.69 $256,265
Purchase
COLELLA SAMUEL D director
 Common Stock 6,778 $13.84 $93,821
Purchase
MERRIFIELD C ANN director
 Common Stock 1,000 $13.39 $13,387
Purchase
VERSANT VENTURES III, LLC 10 percent owner
 Common Stock 714,285 $14 $9,999,990
Purchase
COLELLA SAMUEL D director
 Common Stock 714,285 $14 $9,999,990
Purchase
LUBASH BARBARA N 10 percent owner
 Common Stock 714,285 N/A N/A
Option
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 10,369 $0.16 $1,690
Option
CLAYMAN MICHAEL D. director, officer: President an..
 Stock option (right to buy) 10,369 $0.16 $1,690
Purchase
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 2,000 $10.41 $20,810
Purchase
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 850 $10 $8,500
Purchase
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 2,000 N/A N/A
Purchase
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 2,100 $10.2 $21,420
Purchase
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 2,000 N/A N/A
Purchase
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 800 $9.6 $7,680
Purchase
DRISCOLL FREDERICK W officer: Chief Financial Officer
 Common Stock 2,500 $9.87 $24,668
Purchase
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 2,000 $9.73 $19,466
Purchase
DRISCOLL FREDERICK W officer: Chief Financial Officer
 Common Stock 2,500 $9.19 $22,973
Purchase
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 1,250 $9.4 $11,750
Purchase
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 2,000 N/A N/A
Purchase
MERRIFIELD C ANN director
 Common Stock 1,000 $23 $23,000
Sale
NOVO A/S 10 percent owner
 Common Stock 63,412 $20.55 $1,302,863
Sale
NOVO A/S 10 percent owner
 Common Stock 50,888 $20.07 $1,021,220
Sale
NOVO A/S 10 percent owner
 Common Stock 35,700 $21.51 $767,907
Option
CLAYMAN MICHAEL D. director, officer: President an..
 Common Stock 5,000 $0.16 $815
Option
CLAYMAN MICHAEL D. director, officer: President an..
 Stock option (right to buy) 5,000 $0.16 $815
Sale
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 4,000 N/A N/A
Sale
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 4,000 $24.26 $97,056
Sale
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 4,000 $23.45 $93,792
Sale
BODICK NEIL officer: Chief Scientific Officer
 Common Stock 4,000 $22.44 $89,768
Purchase
NOVO A/S 10 percent owner
 Common Stock 500,000 N/A N/A
Sale
SOFINNOVA PARTNERS SAS 10 percent owner
 Common Stock 10,000 $20 $200,000
Purchase
NOVO A/S 10 percent owner
 COMMON STOCK 692,308 $13 $9,000,004
Purchase
SOFINNOVA PARTNERS SAS 10 percent owner
 Common Stock 230,769 $13 $2,999,997
Purchase
VERSANT VENTURE CAPITAL III, L.P. 10 percent owner
 Common Stock 307,692 $13 $3,999,996
Purchase
BOLZON BRADLEY J PHD 10 percent owner
 Common Stock 307,692 $13 $3,999,996
Purchase
COLELLA SAMUEL D director
 Common Stock 307,692 $13 $3,999,996
Purchase
TORDJMAN RAFAEL director, 10 percent owner
 Common Stock 230,769 $13 $2,999,997

Showing 100 to 137 of 137 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: